CBMR Innovation Summit on cardiometabolic health

The CBMR Innovation Team (CBMR/innovation) is organizing a two-day high-profile Innovation Summit with a focus on cardiometabolic health and disease taking place on October 30–November 1, 2024, in central Copenhagen, Denmark. Please find the tentative program below.

Program & registration

Registration will open closer to the event.

Aim & topics

The conference aims to bring together global leaders from academia, biotech, pharma and the healthcare sector to focus on next-generation prevention and treatment strategies for cardiometabolic disease. Topics that will be delved into further in the form of keynote lectures, talks and constructive panel debates include:

  1. Current gaps/opportunities/perspectives in cardiometabolic disease innovation
  2. Entrepreneurial success stories and lessons learned
  3. From lab to clinic – improving current support structures
  4. Identifying and overcoming obstacles/knowledge gaps


Trine Bartholdy CIO, BioInnovation Institute, DK
Matthew Coghlan – Associate Vice President, Eli Lilly, UK
Richard DiMarchi – Professor, Indiana University Bloomington, US
Casper Tind Hansen – CEO Embark Laboratories, DK
Anders Hinsby – COO, Muna Therapeutics, DK
Johan Kördel – Managing Partner, Sound Bioventures, DK
Martin Holst Lange – Executive Vice President, Development Novo Nordisk AS, DK
Stinus Lindgreen – Member of Danish Parlament, DK
Lars Bo Nielsen – Director, Danish Medical Agency, DK
Jens B Nielsen – CEO, BioInnovation Institute, DK
Jørgen Søberg Petersen – Partner Novo Holdings, DK
Nancy Thornberry – Founding CEO & Chair, Kallyope, US
Anne Tybjærg-Hansen – Clinical Professor, University of Copenhagen, DK
Jan G J van de Winkel – President & CEO, Genmab, DK
Niels Vrang – CSO, Gubra, DK
John Wilding – Professor of Medicine, University of Liverpool, UK
Ashley Zehnder – CEO Fauna Bio, US
Feng Zhang – Professor MIT and Harvard, USA





Organizing Committee:

CBMR Innovation Team:

Christoffer Clemmensen – Innovation Lead, Group Leader
Kei Sakamoto – Vice Executive Director, Group Leader
Zach Gerhart-Hines – Group Leader
Thue W. Schwartz – Group Leader
Thomas Frimurer – Head of Computational Chemistry Unit
Imke Tiessen – Innovation Coordinator